(Q39420474)

11 September 2017

title

Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation (English)

1 reference

11 September 2017

1 reference

Makoto Sahara

1

1 reference

11 September 2017

Masayasu Ikutomi

2

1 reference

11 September 2017

Toshihiro Morita

3

1 reference

11 September 2017

Yoshiyasu Minami

4

1 reference

11 September 2017

Toshiaki Nakajima

5

1 reference

11 September 2017

Yasunobu Hirata

6

1 reference

11 September 2017

Ryozo Nagai

7

1 reference

11 September 2017

Masataka Sata

8

1 reference

11 September 2017

publication date

4 November 2013

1 reference

11 September 2017

published in

Cardiovascular Research

1 reference

11 September 2017

volume

101

1 reference

11 September 2017

issue

2

1 reference

11 September 2017

page(s)

236-246

1 reference

Gain-of-function mutant of angiotensin II receptor, type 1A, causes hypertension and cardiovascular fibrosis in mice

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT245

Renin-angiotensin system and atherothrombotic disease: from genes to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT245

Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT245

Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT245

Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT245

Irbesartan but not amlodipine suppresses diabetes-associated atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT245

A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT245

Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT245

Angiotensin-converting enzyme 2 protects from severe acute lung failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT245

Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT245

Regulation of ACE2 in cardiac myocytes and fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT245

Angiotensin-converting enzyme 2 is an essential regulator of heart function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT245

Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT245

Effects of ACE2 Inhibition in the Post-Myocardial Infarction Heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT245

Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT245

Candesartan ameliorates cardiac dysfunction observed in angiotensin-converting enzyme 2-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT245

Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT245

Organ-specific distribution of ACE2 mRNA and correlating peptidase activity in rodents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT245

Angiotensin II AT1 receptors regulate ACE2 and angiotensin-(1-7) expression in the aorta of spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT245

Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT245

Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT245

Diverse contribution of bone marrow-derived cells to vascular remodeling associated with pulmonary arterial hypertension and arterial neointimal formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT245

Angiotensin II type 1 receptor-induced extracellular signal-regulated protein kinase activation is mediated by Ca2+/calmodulin-dependent transactivation of epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT245

Monocyte and macrophage dynamics during atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT245

AMPKα2 deletion exacerbates neointima formation by upregulating Skp2 in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT245

Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT245

Angiotensin II receptor blocker inhibits neointimal hyperplasia through regulation of smooth muscle-like progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT245

Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT245

Enhanced atherosclerosis and kidney dysfunction in eNOS(-/-)Apoe(-/-) mice are ameliorated by enalapril treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT245

Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT245

ACE2 overexpression inhibits angiotensin II-induced monocyte chemoattractant protein-1 expression in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT245

Ebselen inhibits tumor necrosis factor-alpha-induced c-Jun N-terminal kinase activation and adhesion molecule expression in endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT245

Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT245

21 January 2018

Identifiers

DOI

10.1093/CVR/CVT245

1 reference

11 September 2017

1 reference